Cargando…

HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination

Detalles Bibliográficos
Autores principales:	Ngo-Giang-Huong, Nicole, Aghokeng, Avelin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510715/ https://www.ncbi.nlm.nih.gov/pubmed/31143873 http://dx.doi.org/10.1016/j.eclinm.2019.03.013

Ejemplares similares

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2019)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008–2010: lessons and challenges for low-resource settings
por: Fokam, Joseph, et al.
Publicado: (2013)

Enhancing HIV Treatment Access and Outcomes Amongst HIV Infected Children and Adolescents in Resource Limited Settings
por: Goga, Ameena Ebrahim, et al.
Publicado: (2016)

Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World
por: McCune, Joseph M., et al.
Publicado: (2021)

Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010
por: Billong, Serge C., et al.
Publicado: (2012)

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

Elimination of Vertical Transmission of HIV and Syphilis as a Public Health Threat in India: Strategic Information-Driven Pathway
por: Kumar, Pradeep, et al.
Publicado: (2022)

Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon
por: Penda, Calixte Ida, et al.
Publicado: (2022)

Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention
por: Montague, Brian T, et al.
Publicado: (2011)

Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
por: Aghokeng, Avelin F., et al.
Publicado: (2009)

Strengthening human resources for health in resource-limited countries: The case of Medic to Medic in Malawi
por: Bickton, Fanuel Meckson, et al.
Publicado: (2019)

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV
por: Ruel, Theodore, et al.
Publicado: (2023)

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
por: Manasa, Justen, et al.
Publicado: (2014)

Towards the Elimination of Pediatric HIV: Enhancing Maternal, Sexual, and Reproductive Health Services
por: Hairston, Alana F., et al.
Publicado: (2012)

HIV drug resistance testing – The quest for Point-of-Care
por: Noguera-Julian, Marc
Publicado: (2019)

OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories
por: Panpradist, Nuttada, et al.
Publicado: (2019)

Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting
por: Kwizera, Richard, et al.
Publicado: (2020)

The ESTHER hospital partnership initiative: a powerful levy for building capacities to combat the HIV pandemic in low-resource countries
por: Raguin, Gilles
Publicado: (2016)

Improving HIV outcomes in resource-limited countries: the importance of quality indicators
por: Ahonkhai, Aima A, et al.
Publicado: (2012)

Pre-treatment HIV drug resistance testing cost-effectiveness
por: van de Vijver, David AMC, et al.
Publicado: (2020)

WHO urges action against HIV drug resistance threat
Publicado: (2017)

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance
por: Billong, Serge C., et al.
Publicado: (2013)

Following the elite: Targeting immunometabolism to limit HIV pathogenesis
por: Routy, Jean-Pierre, et al.
Publicado: (2019)

Following the path: Increasing trends of HIV-1 drug resistance in China
por: Gupta, Soham, et al.
Publicado: (2020)

Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials
por: Chua, Rayeil J., et al.
Publicado: (2022)

Postgraduate and research programmes in Medicine and Public Health in Rwanda: an exciting experience about training of human resources for health in a limited resources country
por: Kakoma, Jean Baptiste
Publicado: (2016)

HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa
por: Engone-Ondo, Jéordy D, et al.
Publicado: (2022)

Cultural Approach to HIV/AIDS Harm Reduction in Muslim Countries
por: Hasnain, Memoona
Publicado: (2005)

Human genomics and preparedness for infectious threats
por: Dowling, Nicole F, et al.
Publicado: (2009)

HIV treatment and care in resource-constrained environments: challenges for the next decade
por: Eholié, Serge-Paul, et al.
Publicado: (2012)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance
por: Daria, Sohel, et al.
Publicado: (2022)

Coronavirus Disease 2019 in 5 Neighboring Limited-Resource Countries: A Financial and Health Threat
por: Hussain, Yaseen, et al.
Publicado: (2021)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

In developed countries male circumcision prevalence is inversely related to HIV prevalence
por: Morris, Brian J., et al.
Publicado: (2015)

The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
por: Rojo, Pablo, et al.
Publicado: (2020)

Frontier injustice: the American threat to Canada’s drug supply
por: Houston, Adam R., et al.
Publicado: (2019)

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance
por: Günthard, Huldrych F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ln9rf017tdcns3tubl4ececfar